Research Medical Center June 15, 2017

WHO: Research Medical Center

WHAT: Reveal/Tour of Gamma Knife ICON Technology and Suite

WHEN: 4:30 p.m. - 6 p.m., Monday, June 19, 2017

WHERE: Research Medical Center, Medical Office Building 2330 E. Meyer Blvd., Kansas City, MO 64132

FOR MEDIA ESCORT TO EVENT: Please go to Medical Office Building entrance 2330 E. Meyer Blvd.

WHY: Research Medical Center—part of HCA Midwest Health, Kansas City’s leading healthcare provider—was the first in the region to use the cutting-edge Gamma Knife technology in 1994. The most advanced cranial stereotactic radiosurgery, Gamma Knife is an alternate to conventional open brain surgery and traditional radiation therapy. The sophisticated system, which has been used to treat more than 1 million patients worldwide since 1968, treats brain conditions such as metastatic brain cancer, acoustic neuroma, trigeminal neuralgia, arteriovenous malformations and tremors, among others, without incisions, general anesthesia or an overnight hospital stay.

Now the Gamma Knife ICON, the sixth generation of the most commonly used stereotactic radiosurgery and the most precise currently available, offers physicians expansion into new treatment areas. The frameless mask solution is one of several new features of ICON and is integrated with a novel high definition motion management.

“The Gamma Knife ICON is an exciting breakthrough for treating patients with many brain conditions,” says Jonathan Chilton, M.D., accomplished board certified neurosurgeon and Medical Director of the Midwest Gamma Knife Center, the first dedicated cranial radiosurgery facility in the five-state Midwest region. “ICON was designed to enable treatment of virtually any target in the brain, especially difficult-to-access areas—from refractory essential tremor and complex vascular malformations to multiple metastases—while delivering the lowest dose of radiation to healthy tissues. It offers unprecedented accuracy and treats more than cancer, such as trigeminal neuralgia, which is sometimes resistant to medications.”

Additionally, with Gamma Knife there is a two- to four-fold improvement in sparing normal brain tissue compared to other linear accelerator platforms.

“These features allow for greater potential to protect patient quality of life both during treatment and after recovery,” Chilton says. “It’s life-saving/life-extending treatment for persons diagnosed with certain types of brain tumors.”

“Research Medical Center is pleased to offer patients in the region the latest advance in Gamma Knife radiosurgery, the most clinically proven radiosurgery technique,” says Jackie DeSouza-Van Blaricum, Chief Executive Officer, Research Medical Center. “We strive to give neurosurgeons and radiation oncologists the tools they need to effectively treat the target and protect healthy brain tissue. Gamma Knife ICON exemplifies that commitment and brings a new treatment option to people living with brain diseases.”

Research Medical Center will treat its first patient with the Gamma Knife ICON on Monday, June 26.

For more information on the Gamma Knife ICON, visit Sarah Cannon Cancer Institute at Research Medical Center at http://researchmedicalcenter.com/service/cancer-care or call 816-276-4262.